RVG‐IL3 NGs are precisely delivered into microglia and dopaminergic neuron in the brain, and it ameliorates motor deficits and pathological α‐synuclein in mouse models of Parkinson’s disease. This evidence concerns the gene IL3 and Parkinson disease.